Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “STAGE IIIB OR IV NON-SMALL CELL LUNG CANCER”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01955421
What this trial is testing

Erlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant Nsclc

Who this might be right for
Advanced Stage Non Small Cell Lung Cancer
Sun Yat-sen University 224
Not applicableEnrolling By InvitationNCT06715501
What this trial is testing

Efficacy and Safety of Cadonilimab and Chemoradiotherapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Esophageal Squamous Cell CarcinomaII-IIIB Stages
First Affiliated Hospital of Ningbo University 20
Not applicableStudy completedNCT01982500
What this trial is testing

Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hellenic Oncology Research Group 200
Testing effectiveness (Phase 2)Study completedNCT02366195
What this trial is testing

Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma

Who this might be right for
Unresected Stage IIIb to IVM1c Melanoma
Amgen 112
Testing effectiveness (Phase 2)Study completedNCT02593175
What this trial is testing

Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC

Who this might be right for
Stage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7Stage IB Breast Cancer AJCC v7+8 more
M.D. Anderson Cancer Center 43
Post-approval studies (Phase 4)UnknownNCT03017872
What this trial is testing

Dolutegravir and Darunavir Evaluation in Adults Failing Therapy

Who this might be right for
HIV Infections
Kirby Institute 831
Not applicableUnknownNCT03322072
What this trial is testing

Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating

Who this might be right for
Lung Cancer Stage ILung Cancer Stage IILung Cancer, Nonsmall Cell+2 more
CancerCare Manitoba 28
Testing effectiveness (Phase 2)Study completedNCT02014441
What this trial is testing

Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec

Who this might be right for
Melanoma
Amgen 61
Early research (Phase 1)Study completedNCT03095781
What this trial is testing

Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Colorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Colorectal Carcinoma+12 more
Emory University 47
Large-scale testing (Phase 3)Study completedNCT00775645
What this trial is testing

S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityFatigue+2 more
SWOG Cancer Research Network 437
Testing effectiveness (Phase 2)Ended earlyNCT00722072
What this trial is testing

Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
OHSU Knight Cancer Institute 12
Not applicableWithdrawnNCT05093712
What this trial is testing

Patient-Informed Educational Intervention for the Improvement of Cervical Cancer Literacy

Who this might be right for
Stage IB Cervical Cancer FIGO 2018Stage IB1 Cervical Cancer FIGO 2018Stage IB2 Cervical Cancer FIGO 2018+13 more
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)WithdrawnNCT00403182
What this trial is testing

Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Technical University of Munich
Testing effectiveness (Phase 2)Study completedNCT01296113
What this trial is testing

Chemotherapy for Lung Cancer in HIV-positive Patients

Who this might be right for
Non-small Cell Lung CancerHiv-positive
Intergroupe Francophone de Cancerologie Thoracique 61
Testing effectiveness (Phase 2)Study completedNCT00923312
What this trial is testing

Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
CureVac 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05925530
What this trial is testing

Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 142
Not applicableStudy completedNCT00959244
What this trial is testing

Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105

Who this might be right for
Breast Cancer
University of Nebraska 100
Not applicableTemporarily pausedNCT04981834
What this trial is testing

Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer

Who this might be right for
Stage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8+6 more
University of Southern California 196
Testing effectiveness (Phase 2)Study completedNCT02927301
What this trial is testing

Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc. 181
Early research (Phase 1)Study completedNCT02206334
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer

Who this might be right for
Male Breast CarcinomaProstate AdenocarcinomaRecurrent Breast Carcinoma+5 more
NRG Oncology 42
Next Page